Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is administered as a once-weekly subcutaneous injection using a pre-filled KwikPen. Each pen contains four weekly doses, delivered just beneath the skin into the abdomen, thigh, or upper arm. The injection takes seconds and uses a fine, short needle designed to minimise discomfort — no clinical training required to use it at home. Because Mounjaro is a prescription-only medicine, a prescriber must assess your suitability before you receive a pen; how tirzepatide is administered is straightforward once that's in place, and the pen mechanism guides you through it. The NHS medicines page for tirzepatide covers the essentials, and the Patient Information Leaflet inside your pack gives the full step-by-step detail.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You've just received your Mounjaro pen. It's smaller than most people expect, about the size of a chunky marker pen. One common misconception is that self-injecting a weight-loss medicine is a clinical procedure, something you'd need training for. It isn't. The KwikPen does most of the work. The needle is concealed before, during and after the injection, which takes the guesswork out of depth and angle.
Choose your site: most people start with the abdomen, a couple of centimetres away from the navel. Pinch a small fold of skin gently, press the pen flat against it until you hear a click, hold it steady for a full ten seconds, then remove. That's the complete physical act. The ten-second hold matters, it ensures the full dose is delivered and reduces the chance of a small welt forming at the site.
For a close-up walkthrough, our video guide on administering Mounjaro shows the process in real time, which many patients find more useful than reading about it. If you want to work through the steps in writing first, our step-by-step administration guide covers them in order.
The three licensed sites for how tirzepatide is administered are the abdomen, the front of the thigh, and the outer upper arm. Each one gives access to the subcutaneous tissue layer just beneath the skin, where the medicine is absorbed gradually into the bloodstream.
Rotating sites prevents a build-up of scar tissue or lipohypertrophy, which can reduce absorption over time. A practical rhythm some patients adopt: abdomen on the first week, thigh on the second, upper arm on the third, then repeat. You can also move within a site (different spots on the same area of abdomen, for example) as long as each injection lands at least 2 cm from the last one.
Injection-site reactions (mild redness, itching, a small lump) are among the most commonly reported early experiences and almost always settle within a day or two. If you notice persistent swelling or hardening at a site, that's a reason to rotate more deliberately. Our guide to choosing the best injection site goes into more depth on the practical differences between locations.
There's a fuller overview of tirzepatide as a treatment (including how it works at a receptor level) on our tirzepatide information page.
How Mounjaro is administered successfully over months isn't just technique, it's consistency. A few practical points shape that.
Pens live in the fridge. Storing them above 8°C for longer than the window specified in the leaflet means the dose is no longer reliable, so treat refrigeration as non-negotiable on ordinary weeks. The exact room-temperature limit varies and the leaflet in your pack is the authority on this; don't rely on memory or online estimates.
Injection day is yours to choose, but the same day each week keeps levels stable. If you shift days, do so by no more than three days in either direction and only when genuinely necessary, a prescriber is the right person to ask if you need to adjust your schedule. One thing to keep in mind: lethargy and low energy in the hours after injecting are something patients mention to our clinical team more than you might expect. Our page on Mounjaro and fatigue unpacks what's behind it and when it warrants a conversation with a prescriber.
Alcohol swabs are useful for cleaning the injection site first. Used needles must go into a sharps container, not the household bin. If you need one, they're available from most pharmacies. Novo disposable needles should be changed with every injection; reusing them blunts the tip and increases discomfort.
For a broader look at what treatment involves from the start, our Mounjaro overview page covers licensing, eligibility and what to expect across the full course. If you're thinking about the cost side, our page on the recent Lilly UK price change gives the clearest current picture of private pricing. And for anyone ready to see whether they're clinically suitable, the free consultation is the place to start, a real prescriber reviews every application, not software.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.